Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A14NKG / Name: Invitae / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Invitae Corp Stock

Our community identified positive and negative aspects for Invitae Corp stock for the coming years. 5 users see the criterium "Worthwhile Investment for the next years" as a plus for the Invitae Corp stock. On the other hand our users think that "EBIT growth" could be a problem in the future.

Pros and Cons of Invitae Corp in the next few years

Pros
?
G***** c******* t* c**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Invitae Corp vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Invitae Corp - - - - - - -
Ironwood Pharmaceuticals -0.670% -1.342% -6.369% -28.641% -29.327% -17.416% -36.856%
Novocure Ltd -0.620% -14.085% -11.150% -80.505% -20.736% -92.957% -
Iovance Biotherapeutics Inc. -0.550% -10.456% -14.690% 112.370% 40.945% -56.277% -

Comments

Sell Invitae Corp
Show more

News

Is Invitae Stock a Buy Now?: https://g.foolcdn.com/editorial/images/762971/gettyimages-1072035598.jpg
Is Invitae Stock a Buy Now?

Invitae (NYSE: NVTA) has grown revenue over time, but the genetic testing specialist has failed to turn that into profit. Instead, the company burned through more and more cash, prompting it to

Invitae (NVTA) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Invitae (NVTA) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Invitae (NYSE: NVTA)Q3 2023 Earnings CallNov 08, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

3 Things About Invitae Every Smart Investor Knows: https://g.foolcdn.com/editorial/images/753343/researcher-loads-diagnostic-analyzer.jpg
3 Things About Invitae Every Smart Investor Knows

Genetic-testing company, Invitae (NYSE: NVTA), isn't as easy to understand as it might seem. After more than a year of pivoting and scaling down its operations, changing its leadership, and